CoChat

Painful and non-painful diabetic neuropathy, diagnostic challenges and implications for future management

Open access

The DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.

Abstract

Peripheral neuropathy is one of the most common complications of both type 1 and type 2 diabetes. Up to half of patients with diabetes develop neuropathy during the course of their disease, which is accompanied by neuropathic pain in 30–40% of cases. Peripheral nerve injury in diabetes can manifest as progressive distal symmetric polyneuropathy, autonomic neuropathy, radiculo-plexopathies, and mononeuropathies. The most common diabetic neuropathy is distal symmetric polyneuropathy, which we will refer to as DN, with its characteristic glove and stocking like presentation of distal sensory or motor function loss. DN or its painful counterpart, painful DN, are associated with increased mortality and morbidity; thus, early recognition and preventive measures are essential. Nevertheless, it is not easy to diagnose DN or painful DN, particularly in patients with early and mild neuropathy, and there is currently no single established diagnostic gold standard. The most common diagnostic approach in research is a hierarchical system, which combines symptoms, signs, and a series of confirmatory tests. The general lack of long-term prospective studies has limited the evaluation of the sensitivity and specificity of new morphometric and neurophysiological techniques. Thus, the best paradigm for screening DN and painful DN both in research and in clinical practice remains uncertain. Herein, we review the diagnostic challenges from both clinical and research perspectives and their implications for managing patients with DN. There is no established DN treatment, apart from improved glycaemic control, which is more effective in type 1 than in type 2 diabetes, and only symptomatic management is available for painful DN. Currently, less than one-third of patients with painful DN derive sufficient pain relief with existing pharmacotherapies. A more precise and distinct sensory profile from patients with DN and painful DN may help identify responsive patients to one treatment versus another. Detailed sensory profiles will lead to tailored treatment for patient subgroups with painful DN by matching to novel or established DN pathomechanisms and also for improved clinical trials stratification. Large randomized clinical trials are needed to identify the interventions, i.e. pharmacological, physical, cognitive, educational, etc., which lead to the best therapeutic outcomes.

Overview

Integrity signals

Registry

Crossref · 10.1093/brain/awab079

Cites

130 of 130 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Cited by

See all 265

Metadata

Authors
Jensen, T. S., Karlsson, P., Gylfadottir, S. S., Andersen, S. T., Bennett, D. L., Tankisi, H., Finnerup, N. B., Terkelsen, A. J., Khan, K., Themistocleous, A. C., Kristensen, A. G., Itani, M., Sindrup, S. H., Andersen, H., Charles, M., Feldman, E. L., & Callaghan, B. C.
Affiliations
  • Aarhus University (DK)
  • Danish Pain Research Center, Aarhus University, Aarhus, Denmark
  • University of Oxford (GB)
  • Department of Neurophysiology, Aarhus University Hospital, Aarhus, Denmark
  • Aarhus University Hospital (DK)
  • Odense University Hospital (DK)
  • University of Michigan (US)
Corresponding author
Jensen, Troels S
Venue
Brain
Published
2021-03-12
Volume
144
Issue
6
Pages
1632-1645
ISSN
  • 0006-8950 (ISSN-L)
  • 1460-2156
OpenAlex
W3133602036
Cited by
265
References
130
Citations by year
2026: 46 · 2025: 72 · 2024: 64 · 2023: 45 · 2022: 31 · 2021: 7
FWCI
4.90
Type
journal article
Language
en
Open access
Locations
  • Brain (publishedVersion)
  • PubMed Central (publishedVersion)
  • University of Southern Denmark Research Portal (University of Southern Denmark) (publishedVersion, other-oa)
  • PubMed (publishedVersion)
Funders
  • Novo Nordisk Foundation (14OC0011633, 18OC0052301)
  • European Commission Horizon 2020 (ID633491)
  • Independent Research Fund Denmark (0134-00223B)
  • National Institutes of Health (R24 DK082841, R01 DK107956)
  • NIH (R01 DK115687)
Topics
  • Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
  • Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
  • Health Sciences › Medicine › Oncology › Cancer Treatment and Pharmacology
Keywords
diabetic neuropathy, diabetic neuropathic pain, neuropathic pain, distal symmetric polyneuropathy, autonomic neuropathy, mononeuropathy, neuropathy diagnosis, neuropathy screening, glycemic control, sensory profile, clinical trial stratification, type 1 diabetes, type 2 diabetes
MeSH terms
Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diabetic Neuropathies, Humans, Neuralgia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.